These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 155894)

  • 1. A sensitive fluorescent assay for determining alpha2-plasmin inhibitor using a synthetic substrate.
    Lawson DE; Mitchell GA; Huseby RM
    Thromb Res; 1979; 14(2-3):323-32. PubMed ID: 155894
    [No Abstract]   [Full Text] [Related]  

  • 2. Assay of alpha2-plasmin inhibitor activity by means of a plasmin specific tripeptide substrate.
    Naito K; Aoki N
    Thromb Res; 1978 Jun; 12(6):1147-56. PubMed ID: 151345
    [No Abstract]   [Full Text] [Related]  

  • 3. Plasmin-antiplasmin complex formation during defibrase infusion in man.
    Collen D; Verstraete M
    Thromb Res; 1977 Sep; 11(3):417-20. PubMed ID: 144333
    [No Abstract]   [Full Text] [Related]  

  • 4. Inhibition of plasmin by normal and antiplasmin-depleted human plasma.
    Edy J; De Cock F; Collen D
    Thromb Res; 1976 Apr; 8(4):513-8. PubMed ID: 131986
    [No Abstract]   [Full Text] [Related]  

  • 5. Studies on plasma antiplasmin activity using a new plasmin specific chromogenic tripeptide substrate.
    Gallimore MJ; Amundsen E; Aasen AO; Larsbraaten M; Lyngaas K; Svendsen L
    Thromb Res; 1979 Jan; 14(1):51-60. PubMed ID: 154751
    [No Abstract]   [Full Text] [Related]  

  • 6. Alpha2-plasmin inhibitor and alpha2-macroglobulin-plasmin complexes in plasma. Quantitation by an enzyme-linked differential antibody immunosorbent assay.
    Harpel PC
    J Clin Invest; 1981 Jul; 68(1):46-55. PubMed ID: 6166634
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Kinetics of plasmin inhibition in the presence of a synthetic tripeptide substrate. The reaction with pancreatic trypsin inhibitor and two forms of alpha 2-plasmin inhibitor.
    Petersen LC; Clemmensen I
    Biochem J; 1981 Oct; 199(1):121-7. PubMed ID: 6175313
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The alpha2-plasmin inhibitor levels in liver diseases.
    Aoki N; Yamanaka T
    Clin Chim Acta; 1978 Mar; 84(1-2):99-105. PubMed ID: 76519
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plasmin inhibitor interactions. The effectiveness of alpha2-plasmin inhibitor in the presence of alpha2-macroglobulin.
    Harpel PC
    J Exp Med; 1977 Oct; 146(4):1033-40. PubMed ID: 70499
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of plasmin by beta-lactoglobulin using casein and a synthetic substrate.
    Bastian ED; Hansen KG; Brown RJ
    J Dairy Sci; 1993 Nov; 76(11):3354-61. PubMed ID: 8270680
    [TBL] [Abstract][Full Text] [Related]  

  • 11. On the kinetics of the reaction between human antiplasmin and plasmin.
    Wiman B; Collen D
    Eur J Biochem; 1978 Mar; 84(2):573-8. PubMed ID: 147769
    [No Abstract]   [Full Text] [Related]  

  • 12. The behavior of alpha2-plasmin inhibitor in fibrinolytic states.
    Aoki N; Moroi M; Matsuda M; Tachiya K
    J Clin Invest; 1977 Aug; 60(2):361-9. PubMed ID: 68962
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development of a latex immunoturbidimetric assay for the automated measurement of alpha2 plasmin inhibitor-plasmin complex in human plasma.
    Fujimoto T; Nakamura K; Nishihira J
    Semin Thromb Hemost; 1999; 25(6):551-6. PubMed ID: 10632477
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A new fluorogenic substrate for plasmin.
    Pierzchala PA; Dorn CP; Zimmerman M
    Biochem J; 1979 Dec; 183(3):555-9. PubMed ID: 161507
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of plasmin by fibrinogen.
    Higazi AA; Mayer M
    Biochem J; 1990 Jul; 269(2):299-302. PubMed ID: 2143650
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Heparin and protease inhibition. II. The role of heparin in the ATIII inactivation of thrombin, plasmin, and trypsin.
    Smith GF; Sundboom JL
    Thromb Res; 1981 Apr 1-15; 22(1-2):115-33. PubMed ID: 6457414
    [No Abstract]   [Full Text] [Related]  

  • 17. Plasmin inactivation in plasma.
    Haselager EM; Goote TM; Vreeken J
    Thromb Haemost; 1976 Jun; 35(3):643-50. PubMed ID: 62411
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Assay of functional plasminogen in rat plasma applicable to experimental studies of thrombolysis.
    Bangert K; Thorsen S
    Thromb Haemost; 2000 Aug; 84(2):299-306. PubMed ID: 10959704
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis and evaluation of tripeptidic plasmin inhibitors with nitrile as warhead.
    Teno N; Otsubo T; Gohda K; Wanaka K; Sueda T; Ikeda K; Hijikata-Okunomiya A; Tsuda Y
    J Pept Sci; 2012 Oct; 18(10):620-5. PubMed ID: 22961872
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Determination of fast-acting plasmin inhibitor (alpha2-antiplasmin) in plasma from patients with tendency to thrombosis and increased fibrinolysis.
    Teger-Nilsson AC; Gyzander E; Myrwold H; Noppa H; Olsson R; Wallmo L
    Haemostasis; 1978; 7(2-3):155-7. PubMed ID: 149047
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.